Although much information has been accumulated on the process of cytolysis by thymus-dependent (T) 1 lymphocytes, the precise biochemical basis for the lytic mechanism is still unclear. The present knowledge of the subject has recently received extensive review (1-3). Three approaches have been adopted for the study of the metabolic processes essential for T-cell-mediated cytolysis. First, experiments have been carried out using support media which have been deprived of primary metabolic substrates. For example, assessment of cytolysis has been performed in glucose-free medium, under anaerobic conditions (4), or in the absence of divalent cations (5). Second, drugs have been used to block cytolysis and the findings have been interpreted in relation to the reported major effects of these drugs on metabolic processes. However, in general no control has been provided to indicate that the observed effect on cytolysis was causally linked to the reported metabolic effects. This approach has been fully reviewed by Martz (2). Finally, competitive inhibitors have been used, with a check on the specificity of their action through reversal of their effect with excess normal substrate. Probably the best example of such an approach has been the recent work of MacDonald (6) using 2-deoxy-D-glucose as an inhibitor of cytolysis, and D-glucose or D-glucose analogs to achieve reversal. These results appear to have formally established a role for glucose or a glucose analog in T-cell-mediated cytolysis. Interestingly, some of MacDonald's results indicated that glucose might not be acting simply as an energy source.Most previous investigations with drugs, including 2-deoxy-D-glucose, have failed to establish at which stage(s) of cytolysis the agents were acting. T-cellmediated cytolysis can now be considered as a complex phenomenon including a number of discrete stages (7,8). The first recognition stage is followed by the "lethal hit" stage during which an irreversible lesion is inflicted upon the target